The University at Buffalo (N.Y.) partnered with Buffalo-based startup Garwood Medical Devices to evaluate a device for amputee patients, according to a Dec. 2 press release.
Together they were awarded about $750,000 to evaluate Garwood's BioPrax device, which was developed to eliminate bacterial biofilm infections associated with orthopedic implants, the release said. The device uses a cathodic voltage-controlled electrical stimulation to kill bacteria on implants, such as a prosthetic knee.
The grant funding, awarded by the Peer Reviewed Orthopedic Research Program of the Congressionally Directed Medical Research Programs, will allow the team to explore the potential for a new clinical application for the BioPrax technology, the release said. Their goal will be to evaluate how the system can be used to enhance wound healing and infection control for those using prosthetic limbs.
Read more here.